NewsMarketsSecond Cannabis Investment For UK Tobacco Firm

Second Cannabis Investment For UK Tobacco Firm

-

BRITISH tobacco giant Imperial has demonstrated its ambition in the legal cannabis industry with a second foray into the sector.

A recent £75m investment will provide Canadian firm Auxly Cannabis Group access to Imperial’s vaping technology.

This follows its initial investment into fellow UK firm Oxford Cannabis Technologies (OCT) in June, 2018.

Imperial, which makes the Lambert & Butler and Golden Virginia tobacco brands, say the Auxly move is part of an ongoing diversification strategy, which has seen it develop a growing presence in the heated tobacco and electronic vaping sectors.

Matthew Phillips, Imperial’s Chief Development Officer said: “Diversifying our Next Generation Product portfolio with this investment provides Imperial with further options for future growth and builds on last year’s investment in Oxford Cannabinoid Technologies.” 

Toronto-listed Auxly is strongly focused on developing the ‘Generation 2’ Canadian cannabis products, namely; edibles, vapes and lotions which were approved for sale last last year.

The deal gives Bristol-based Imperial a 19.9% stake in Auxly through a three-year convertible loan at a price of 81 cents per share.

OCT is a medical cannabis research company, Backed by Snoop Dogg’s venture firm and Star Wars actor Patrick Stewart, which says it aims to ‘unravel the secrets of a plant that has been stigmatised for decades’. 

Imperial is the latest consumer goods company to make a foray into cannabis. Last year Marlboro maker Altria Group announced a $2.4 billion investment in Cronos Group. 

Tilray has struck an agreement to collaborate on medical cannabis with Sandoz AG, part of the Novartis pharmaceutical Group and Canada’s Canopy Growth is receiving over $5 billion of investment from alcohol giant Constellation Brands.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

‘Collaborative Vertical Integration Has To Be The Way Forward For the European Cannabis Industry’

BACK in 2019 at a US industry conference while discussing cannabis business models a top executive from JP...

Must read

You might also likeRELATED
Recommended to you